The Scientist

» Big Pharma and neuroscience

Most Recent

image: Khaleel Razak: Hearing Engineer

Khaleel Razak: Hearing Engineer

By | September 1, 2015

Associate Professor, Department of Psychology University of California, Riverside. Age: 44

1 Comment

image: Lending an Ear

Lending an Ear

By | September 1, 2015

Until recently, auditory brainstem implants have been restricted to patients with tumors on their auditory nerves.

0 Comments

image: The Ears Have It

The Ears Have It

By | September 1, 2015

A teaching obligation in graduate school introduced James Hudspeth to a career focused on how vertebrates sense sounds.

0 Comments

image: Hearing Help

Hearing Help

By | September 1, 2015

For decades, the only remedies for hearing loss were devices such as hearing aids or cochlear implants. Now, the first pharmaceutical treatments may be on the way.  

2 Comments

image: Oliver Sacks Dies

Oliver Sacks Dies

By | August 31, 2015

The neurologist and author had written about his recent experiences being “face to face with dying.”

0 Comments

image: Legionnaires’ Bacteria at GSK

Legionnaires’ Bacteria at GSK

By | August 14, 2015

GlaxoSmithKline temporarily shuts down a manufacturing plant in North Carolina after Legionella bacteria are detected in two external cooling towers.

0 Comments

image: Eyes Track Dream Scenes

Eyes Track Dream Scenes

By | August 13, 2015

In vivo recordings from humans reveal that brain activity related to seeing pictures correlates with eye movements during REM sleep.

0 Comments

image: Fruit-Fly Neurons in Action

Fruit-Fly Neurons in Action

By | August 12, 2015

Researchers visualize the complete nervous system of a Drosophila melanogaster larva at nearly single-neuron resolution.

0 Comments

image: Chemical Cocktails Produce Neurons

Chemical Cocktails Produce Neurons

By | August 6, 2015

Two research groups have devised small-molecule recipes to directly transform fibroblasts into neurons.

0 Comments

image: Teva Buys Allergan Generics for $40.5 Billion

Teva Buys Allergan Generics for $40.5 Billion

By | July 27, 2015

Meanwhile, Allergan acquires drug developer Naurex in a $560 million deal. 

0 Comments

Popular Now

  1. Gut Microbes Linked to Neurodegenerative Disease
  2. Opinion: WHO’s Silence on Cannabis
  3. Top 10 Innovations 2016
    Features Top 10 Innovations 2016

    This year’s list of winners celebrates both large leaps and small (but important) steps in life science technology.

  4. Infant Microbiome: Vaginal Delivery Versus C-Section
Rockland